По просьбе портала @docma_ru дала комментарии о болезни X в СМИ. Поддалась искушению попытаться снизить накал панических настроений на эту тему.
В статье собраны комментарии нескольких экспертов. Интересно ваше мнение. Какое впечатление у вас после прочтения этого материала?
https://lenta.ru/articles/2024/01/30/chto-takoe-bolezn-x/
#болезньХ #болезньX
BY Infodoc
That strategy is the acquisition of a value-priced company by a growth company. Using the growth company's higher-priced stock for the acquisition can produce outsized revenue and earnings growth. Even better is the use of cash, particularly in a growth period when financial aggressiveness is accepted and even positively viewed.he key public rationale behind this strategy is synergy - the 1+1=3 view. In many cases, synergy does occur and is valuable. However, in other cases, particularly as the strategy gains popularity, it doesn't. Joining two different organizations, workforces and cultures is a challenge. Simply putting two separate organizations together necessarily creates disruptions and conflicts that can undermine both operations.
The seemingly negative pandemic effects and resource/product shortages are encouraging and allowing organizations to innovate and change.The news of cash-rich organizations getting ready for the post-Covid growth economy is a sign of more than capital spending plans. Cash provides a cushion for risk-taking and a tool for growth.
Infodoc from jp